Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and efficacy of intracranially implanted
Carmustine in the treatment of patients with recurrent malignant glioma.